1. Home
  2. EIG vs HELP Comparison

EIG vs HELP Comparison

Compare EIG & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$48.93

Market Cap

911.6M

Sector

Finance

ML Signal

HOLD

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

HOLD

Current Price

$12.40

Market Cap

889.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
HELP
Founded
2000
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
911.6M
889.9M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
EIG
HELP
Price
$48.93
$12.40
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$51.50
AVG Volume (30 Days)
104.5K
1.6M
Earning Date
04-29-2026
07-01-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$858,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.26
N/A
P/E Ratio
$23.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$3.76
52 Week High
$52.59
$14.35

Technical Indicators

Market Signals
Indicator
EIG
HELP
Relative Strength Index (RSI) 48.61 52.58
Support Level $48.30 $11.26
Resistance Level $50.20 $14.35
Average True Range (ATR) 0.94 1.04
MACD 0.02 -0.10
Stochastic Oscillator 40.15 33.76

Price Performance

Historical Comparison
EIG
HELP

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: